Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by GentlemanTraderon May 14, 2020 8:34pm
320 Views
Post# 31030688

RE:Re ACB up 15%

RE:Re ACB up 15%

-EBITDA loss $60M on $75M sales. They need to double the sales to generate a positive cashflow from the operations.They have about 300M in liquidity so more or less 9 months  at this pace before they need to raise additionnal financing.

- ACB current trading value --> 110M shares X 10.42 = 1.1B

- ACB is reporting a book value of 3.9B which accounts for 3B in goodwill and intangible assets. Definition of Goodwill : "The established reputation of a business regarded as a quantifiable asset, e.g., as represented by the excess of the price paid at a takeover for a company over its fair market value"

In other words, ACB is currently trading $200M higher than the book value EXCLUDING the goodwill & IA. 

The
question you need to ask yourself is how much does this GW & IA worth? To be more specific, within all those acquisitions made by ACB, do you value a high potential of  ROI in the very near future. If you don't see any value, your SP buy/sell should be @$8.20 CAD which means if it's trading above that, you should sell or not buy., If you value this @ $500M, then you should take a position if it's below $12.72 CAD or sell if it's higher.If it's $1B, $17.27 CAD and so on.






Bullboard Posts